14-3-3ζ–TRAF5 axis governs interleukin-17A signaling

J McGowan, C Peter, J Kim, S Popli… - Proceedings of the …, 2020 - National Acad Sciences
IL-17A is a therapeutic target in many autoimmune diseases. Most nonhematopoietic cells
express IL-17A receptors and respond to extracellular IL-17A by inducing proinflammatory …

Lactobacillus rhamnosus 2016SWU.05.0601 regulates immune balance in ovalbumin‐sensitized mice by modulating expression of the immune‐related transcription …

J Song, Y Li, J Li, H Wang, Y Zhang… - Journal of the Science of …, 2020 - Wiley Online Library
BACKGROUND Probiotics regulate host immune balance, which may reduce immune‐
related diseases. The effects and mechanisms of Lactobacillus rhamnosus 2016SWU …

Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?

EN Ergen, N Yusuf - Experimental dermatology, 2018 - Wiley Online Library
Immune cells and cytokines play an important role in the pathogenesis of psoriasis.
Interleukin‐12 (IL‐12) and IL‐23 promote cellular responses mediated by T cells, which …

IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-γ/IRF-1 pathway

JR Klune, C Bartels, J Luo, S Yokota… - American Journal of …, 2018 - journals.physiology.org
Interleukin-23 (IL-23) is a proinflammatory cytokine initially studied in autoimmune disease
that has been more recently linked to innate immunity. We observed that the expression of IL …

Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes

A Jörns, D Ishikawa, H Teraoku, T Yoshimoto… - BMC medicine, 2020 - Springer
Background The cytokine IL-17 is a key player in autoimmune processes, while the cytokine
IL-6 is responsible for the chronification of inflammation. However, their roles in type 1 …

Bmi1 regulates IκBα degradation via association with the SCF complex

Y Okuyama, Y Tanaka, JJ Jiang… - The Journal of …, 2018 - journals.aai.org
Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex
PRC1 in the nucleus with no evidently direct link to the NF-κB pathway. In this study, we …

Ингибиторы ИЛ23/ИЛ17 при иммуновоспалительных ревматических заболеваниях: новые горизонты

ЕЛ Насонов, ТВ Коротаева, ТВ Дубинина… - Научно-практическая …, 2019 - cyberleninka.ru
В последние годы большое внимание привлекают ТҺ17-клетки, патологическая
активация которых играет ведущую роль в развитии широкого спектра …

Selective interleukin-23 p19 inhibition: another game changer in psoriasis? Focus on risankizumab

T Torres - Drugs, 2017 - Springer
The history of psoriasis treatment has been marked by several milestones. Corticosteroids,
cyclosporine, tumor necrosis factor alpha (TNF-α) inhibitors and, more recently, interleukin …

Exposure to arsenic and level of Vitamin D influence the number of Th17 cells and production of IL-17A in human peripheral blood mononuclear cells in adults

F Parvez, FT Lauer, P Factor-Litvak, T Islam, M Eunus… - Plos one, 2022 - journals.plos.org
There is limited evidence on the effects of environmental exposure to arsenic (As) on the
immune system in adults. In a population-based study, we have found that urinary As (UAs) …

DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation

G Bian, L Wang, Q Xie, Y Wang, H Feng… - British Journal of …, 2021 - Wiley Online Library
Background and Purpose Psoriasis is a chronic immune‐mediated inflammatory skin
disease that easily recurs and is difficult to cure. DGT is a novel synthetic heterocyclic …